A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
NCT00002163 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the benefit of adding 1592U89 to current antiretroviral therapies for AIDS dementia complex and to assess the safety and tolerance of the treatment regimens.
Conditions
- AIDS Dementia Complex
- HIV Infections
Interventions
- DRUG
-
Abacavir sulfate
Sponsors & Collaborators
-
Glaxo Wellcome
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
NCT00002063 ·Status: COMPLETED ·Phase: NA
-
Minocycline for HIV+ Cognitive Impairment in Uganda
NCT00855062 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
NCT00000657 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
NCT00002246 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
NCT00708110 ·Status: COMPLETED ·Phase: PHASE2
-
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
NCT00361257 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I Study of Methotrexate for HIV Infection
NCT00000834 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
NCT00000794 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
NCT00002316 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of Brentuximab Vedotin in Participants With HIV
NCT05244473 ·Status: WITHDRAWN ·Phase: PHASE1
-
ODYSSEY (PENTA 20)
NCT02259127 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
NCT00046332 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CI-1012 in HIV-Infected Patients
NCT00002196 ·Status: COMPLETED ·Phase: PHASE1
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002032 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00002336 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT00000625 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
NCT00002312 ·Status: COMPLETED ·Phase: NA
-
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002035 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
NCT01933594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase Ib/IIa Clinical Study of ACC017 Tablets
NCT06719310 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
NCT00000738 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
NCT00000803 ·Status: COMPLETED ·Phase: PHASE2